Agile Therapeutics
AGRX
$2.63
Share price
0.00%
Change (1 day)
162.42%
Change (1 year)
Categories
Earnings for Agile Therapeutics (AGRX)
Earnings in 2024 (TTM): -NZ$24.38 Million
According to Agile Therapeutics 's latest financial reports the company's current earnings are NZ$21.56 Million. In 2023 the company made an earning of -NZ$22.72 Million a decrease over its 2022 earnings that were of -NZ$8.34 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Agile Therapeutics from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -NZ$24.38 Million | 7.33% |
| 2023 | -NZ$22.72 Million | 172.57% |
| 2022 | -NZ$8.34 Million | -93.26% |
| 2021 | -NZ$0.13 Billion | 45.62% |
| 2020 | -NZ$84.85 Million | 161.98% |
| 2019 | -NZ$32.39 Million | -2.78% |
| 2018 | -NZ$33.32 Million | -27.47% |
| 2017 | -NZ$45.94 Million | -10.16% |
| 2016 | -NZ$51.13 Million | -14.2% |
| 2015 | -NZ$59.59 Million | 88.45% |
| 2014 | -NZ$31.62 Million | 41.72% |
| 2013 | -NZ$22.32 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -NZ$6.72 Million | -74.31% | 🇺🇸 USA |
 | NZ$0.11 B | -538.45% | 🇺🇸 USA |
 | NZ$30.36 B | -116,178.80% | 🇺🇸 USA |
 | NZ$36.91 B | -141,235.37% | 🇺🇸 USA |
 | NZ$19.34 B | -74,058.47% | 🇺🇸 USA |